0001564590-19-002593 Sample Contracts

Almirall and Dermira Enter into Option and License Agreement for European Rights to Lebrikizumab
Dermira, Inc. • February 12th, 2019 • Pharmaceutical preparations

- Almirall acquires option to license rights to develop and commercialize lebrikizumab for atopic dermatitis in Europe

Sample 1
AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.